2012 RANZCO , The Royal Australian and New Zealand College of Ophthalmologists 44th Annual Scientific Congress

24 November - 28 November 2012 in Melbourne Convention and Exhibition

---

28 Nov 2012

27 Nov 2012

26 Nov 2012

25 Nov 2012

MOST VIEWED ABSTRACTS

---

Twelve month results of the DIMECAT trial: a prospective, randomized clinical trial of intravitreous bevacizumab vs triamcinolone in patients with diabetic macular oedema at the time of cataract surgery

N-ACETYL-CYSTEINE IN OCULAR THERAPY: A REVIEW OF THE LITERATURE

RANZCO CLINICAL AUDIT TOOL (RCAT)

EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES

Intra Ocular Lenses – A comparison of refractive outcomes and complications

Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

Twelve month results of the DIMECAT trial: a prospective, randomized clinical trial of intravitreous bevacizumab vs triamcinolone in patients with diabetic macular oedema at the time of cataract surgery

RANZCO CLINICAL AUDIT TOOL (RCAT)

ARCHIVES